Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancer

被引:0
作者
Yuan Chen
Ruiyuan Xu
Rexiati Ruze
Jinshou Yang
Huanyu Wang
Jianlu Song
Lei You
Chengcheng Wang
Yupei Zhao
机构
[1] Peking Union Medical College,Department of General Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
来源
Cancer Cell International | / 21卷
关键词
Histone modification; Prognostic model; CBX8; CENPT; DPY30; PADI1; Potential drugs; Pancreatic cancer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 707 条
  • [1] Siegel RL(2021)Cancer statistics, 2021 CA Cancer J Clin 71 7-33
  • [2] Miller KD(2021)Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424
  • [3] Fuchs HE(2020)Pancreatic cancer Lancet 395 2008-2020
  • [4] Jemal A(2019)NCCN guidelines updates: pancreatic cancer JNCCN 17 603-605
  • [5] Sung H(2018)International validation of the eighth edition of the American Joint Committee on Cancer (AJCC) TNM staging system in patients with resected pancreatic cancer JAMA Surg 153 e183617-191
  • [6] Ferlay J(2017)Multi-institutional validation study of the American Joint Commission on Cancer (8th edition) changes for T and N staging in patients with pancreatic adenocarcinoma Ann Surg 265 185-275
  • [7] Siegel RL(2012)Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): an emerging field for advanced technologies J Hepatol 56 267-38
  • [8] Laversanne M(2013)The next-generation sequencing revolution and its impact on genomics Cell 155 27-2572
  • [9] Soerjomataram I(2020)Pathway and network analysis of more than 2500 whole cancer genomes Nat Commun 11 729-136
  • [10] Jemal A(2020)Tumor mutational burden and PTEN alterations as molecular correlates of response to PD-1/L1 blockade in metastatic triple-negative breast cancer Clin Cancer Res 26 2565-4569